Мукополисахаридоза тип I (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Мукополисахаридоза тип I" in Serbian language version.

refsWebsite

Global rank Serbian rank

11nih.gov

4^th place

8^th place

10doi.org

2^nd place

4^th place

1whonamedit.com

2,888^th place

3,693^rd place

1worldcat.org

5^th place

12^th place

1archive.org

6^th place

5^th place

1rarediseases.org

5,181^st place

6,243^rd place

archive.org (Global: 6^th place; Serbian: 5^th place)

Wraith, J. E.; Clarke, L. A.; Beck, M; et al. (2004). „Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).”. J Pediatr. 144 (5): 581—88. PMID 15126990. doi:10.1016/j.jpeds.2004.01.046.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Hurler, G. (1919). „Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem”. Zeitschrift für Kinderheilkunde. Berlin. 24 (5–6): 220—234. doi:10.1007/BF02222956.
Moore, David; Connock, Martin J.; Wraith, Ed; Lavery, Christine (2008-1). „The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK”. Orphanet Journal of Rare Diseases. 3. ISSN 1750-1172. PMC 2553763 . PMID 18796143. doi:10.1186/1750-1172-3-24 . Непознати параметар |article-number= игнорисан (помоћ); Проверите вредност парамет(а)ра за датум: |date= (помоћ)
McKusick, V. A., Howell, R. R., Hussels, I. E., Neufeld, E. F., Stevenson, R. E (1972). „Allelism, nonallelism and genetic compounds among the mucopolysaccharidoses.”. Lancet. 299 (7758): 993—996. PMID 4112371. doi:10.1016/S0140-6736(72)91159-2. , 1972. Note: Originally Volume I. [PubMed: 4112371, related citations] [Full Text]
Roubicek, M.; Gehler, J.; Spranger, J. (март 1985). „The clinical spectrum of alpha-L-iduronidase deficiency.”. The American Journal of Medical Genetics. 20 (3): 471—81. PMID 3922223. doi:10.1002/ajmg.1320200308.
Muenzer J and Fisher A (2004). „Advances in the Treatment of Mucopolysaccharidosis Type I”. New Engl J Med. 350 (19): 1932—34. PMID 15128891. doi:10.1056/NEJMp048084. .
Desnick, R. J. (2004). „Enzyme replacement and enhancement therapies for lysosomal diseases.”. J. Inherit Metab Dis. 27 (3): 385—410. PMID 15190196. doi:10.1023/B:BOLI.0000031101.12838.c6.
Wraith, J. E.; Clarke, L. A.; Beck, M; et al. (2004). „Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).”. J Pediatr. 144 (5): 581—88. PMID 15126990. doi:10.1016/j.jpeds.2004.01.046.
Kakkis ED (2002). „Enzyme replacement therapy for the mucopolysaccharides storage disorders”. Expert Opin Investig Drugs. 11 (5): 675—85. PMID 11996648. doi:10.1517/13543784.11.5.675. .
Wraith JE (2001). „Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.”. J Inherit Metab Dis. 24 (2): 245—50. PMID 11405343. doi:10.1023/A:1010379320378. .
Kakkis, E. D.; et al. (2001). „Enzyme-replacement therapy in mucopolysaccharidosis I.”. New England Journal of Medicine. 344 (3): 182—8. PMID 11172140. doi:10.1056/NEJM200101183440304.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Moore, David; Connock, Martin J.; Wraith, Ed; Lavery, Christine (2008-1). „The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK”. Orphanet Journal of Rare Diseases. 3. ISSN 1750-1172. PMC 2553763 . PMID 18796143. doi:10.1186/1750-1172-3-24 . Непознати параметар |article-number= игнорисан (помоћ); Проверите вредност парамет(а)ра за датум: |date= (помоћ)
McKusick, V. A., Howell, R. R., Hussels, I. E., Neufeld, E. F., Stevenson, R. E (1972). „Allelism, nonallelism and genetic compounds among the mucopolysaccharidoses.”. Lancet. 299 (7758): 993—996. PMID 4112371. doi:10.1016/S0140-6736(72)91159-2. , 1972. Note: Originally Volume I. [PubMed: 4112371, related citations] [Full Text]
Roubicek, M.; Gehler, J.; Spranger, J. (март 1985). „The clinical spectrum of alpha-L-iduronidase deficiency.”. The American Journal of Medical Genetics. 20 (3): 471—81. PMID 3922223. doi:10.1002/ajmg.1320200308.
Muenzer J and Fisher A (2004). „Advances in the Treatment of Mucopolysaccharidosis Type I”. New Engl J Med. 350 (19): 1932—34. PMID 15128891. doi:10.1056/NEJMp048084. .
Desnick, R. J. (2004). „Enzyme replacement and enhancement therapies for lysosomal diseases.”. J. Inherit Metab Dis. 27 (3): 385—410. PMID 15190196. doi:10.1023/B:BOLI.0000031101.12838.c6.
Wraith, J. E.; Clarke, L. A.; Beck, M; et al. (2004). „Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).”. J Pediatr. 144 (5): 581—88. PMID 15126990. doi:10.1016/j.jpeds.2004.01.046.
Malm, G.; et al. (2002). „Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis.”. Lakartidningen. 99 (16): 1804—9. PMID 12043480.
Kakkis ED (2002). „Enzyme replacement therapy for the mucopolysaccharides storage disorders”. Expert Opin Investig Drugs. 11 (5): 675—85. PMID 11996648. doi:10.1517/13543784.11.5.675. .
Wraith JE (2001). „Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.”. J Inherit Metab Dis. 24 (2): 245—50. PMID 11405343. doi:10.1023/A:1010379320378. .
Kakkis, E. D.; et al. (2001). „Enzyme-replacement therapy in mucopolysaccharidosis I.”. New England Journal of Medicine. 344 (3): 182—8. PMID 11172140. doi:10.1056/NEJM200101183440304.

ninds.nih.gov

„Mucopolysaccharidoses Fact Sheet”. National Institute of Neurological Disorders and Stroke. 15. 11. 2017. Приступљено 23. 6. 2018.

rarediseases.org (Global: 5,181^st place; Serbian: 6,243^rd place)

Investigational Therapies, У: Мucopolysaccharidosis Type I National Organization for Rare Disorders (NORD)

whonamedit.com (Global: 2,888^th place; Serbian: 3,693^rd place)

Hurler's syndrome на веб-сајту Who Named It (језик: енглески)

worldcat.org (Global: 5^th place; Serbian: 12^th place)

Moore, David; Connock, Martin J.; Wraith, Ed; Lavery, Christine (2008-1). „The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK”. Orphanet Journal of Rare Diseases. 3. ISSN 1750-1172. PMC 2553763 . PMID 18796143. doi:10.1186/1750-1172-3-24 . Непознати параметар |article-number= игнорисан (помоћ); Проверите вредност парамет(а)ра за датум: |date= (помоћ)

Мукополисахаридоза тип I (Serbian Wikipedia)

archive.org (Global: 6th place; Serbian: 5th place)

doi.org (Global: 2nd place; Serbian: 4th place)

nih.gov (Global: 4th place; Serbian: 8th place)